Search results for "Ginecologia"

showing 10 items of 340 documents

Lactobacillus crispatus M247 oral administration: Is it really an effective strategy in the management of papillomavirus-infected women?

2022

Abstract Background Recent studies have shown the importance of the microbiota in women's health. Indeed, the persistence of Human Papilloma Virus (HPV)-related lesions in patients with dysbiosis can be the antechamber to cervical cancer. The aim of this study was to evaluate whether long term administration of oral Lactobacillus crispatus can restore eubiosis in women with HPV infections and hence achieve viral clearance. Methods In total, 160 women affected by HPV infections were enrolled at the Department of Gynecological Obstetrics of “San Paolo” Hospital, Italy between February 2021 and February 2022. The women were randomly assigned to two groups, one in treatment with oral Lactobacil…

Cancer ResearchInfectious DiseasesUterine cervical neoplasmsOncologyLactobacillus crispatus M247EpidemiologyMicrobiotaProbioticsHPV infectionPapillomaviridaeSettore MED/40 - Ginecologia E Ostetricia
researchProduct

Indocyanine Green to Assess Vascularity of Ileal Conduit Anastomosis During Pelvic Exenteration for Recurrent/Persistent Gynecological Cancer: A Pilo…

2021

IntroductionPelvic exenteration performed for recurrent/persistent gynecological malignancies has been associated with urological short- and long-term morbidity due to altered vascularization of tissues for previous radiotherapy. The aims of the present study were to describe the use of intravenous indocyanine green (ICG) to assess vascularity of urinary diversion (UD) after pelvic exenteration for gynecologic cancers, to evaluate the feasibility and safety of this technique, and to assess the postoperative complications.MethodsProspective, observational, single-center, pilot study including consecutive patients undergoing anterior or total pelvic exenteration due to persistent/recurrent gy…

Cancer Researchmajor postoperative complicationsNeoplasms. Tumors. Oncology. Including cancer and carcinogensanastomosisgynecological canceranastomosimajor postoperative complicationeye diseasespelvic exenteration (PE)body regionsileal conduit diversionSettore MED/40 - GINECOLOGIA E OSTETRICIAOncologyindocyanine green (ICG)anastomosis; gynecological cancer; ileal conduit diversion; indocyanine green (ICG); major postoperative complications; pelvic exenteration (PE)RC254-282Original ResearchFrontiers in Oncology
researchProduct

A Multicentric Randomized Trial to Evaluate the ROle of Uterine MANipulator on Laparoscopic/Robotic HYsterectomy for the Treatment of Early-Stage End…

2021

ObjectiveThis prospective randomized trial aimed to assess the impact of the uterine manipulator in terms of lymph vascular space invasion (LVSI) in patients undergoing minimally invasive staging for early-stage endometrial cancer.MethodsIn this multicentric randomized trial, enrolled patients were randomly allocated in two groups according to the no use (arm A) or the use (arm B) of the uterine manipulator. Inclusion criteria were G1-G2 early-stage endometrial cancer at preoperative evaluation. The variables collected included baseline demographic characteristics, perioperative data, final pathology report, adjuvant treatment, and follow-up.ResultsIn the study, 154 patients (76 in arm A an…

Cancer Researchmedicine.medical_specialtyuterine manipulatormedicine.medical_treatmentUrologylaw.inventionRandomized controlled trialminimally invasive hysterectomylawmedicinehysterectomyStage (cooking)RC254-282Original ResearchHysterectomybusiness.industryEndometrial cancerrobotic hysterectomyNeoplasms. Tumors. Oncology. Including cancer and carcinogensPerioperativemedicine.diseaseendometrial cancer; hysterectomy; laparoscopic hysterectomy; minimally invasive hysterectomy; robotic hysterectomy; uterine manipulatorUterine manipulatorRobotic hysterectomyClinical trialSettore MED/40 - GINECOLOGIA E OSTETRICIAOncologyendometrial cancerlaparoscopic hysterectomybusinessFrontiers in Oncology
researchProduct

Assessment of cardiovascular risk and prevention of cardiovascular disease in women with Polycystic Ovary Syndrome: a consensus statement of the Andr…

2010

Women with polycystic ovary syndrome (PCOS) often have cardiovascular disease (CVD) risk factors. The Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society created a panel to provide evidence-based reviews of studies assessing PCOS-CVD risk relationships and to develop guidelines for preventing CVD. Participants: An expert panel in PCOS and CVD reviewed literature and presented recommendations. Evidence: Only studies comparing PCOS with control patients were included. All electronic databases were searched; reviews included individual studies/databases, systematic reviews, abstracts, and expert data. Articles were excluded if other hyperandrogenic disorders were not excluded, PCOS…

Cardiovascular risk PCOS insulin resistance metabolic syndromeSettore MED/11 - Malattie Dell'Apparato CardiovascolareSettore MED/40 - Ginecologia E OstetriciaSettore MED/13 - Endocrinologia
researchProduct

Beyond sentinel node algorithm. Toward a more tailored surgery for cervical cancer patients

2016

none 12 Nowadays cervical cancer is frequently diagnosed at early stage. For these patients lymph node metastasis (LNM) is considered the most important prognostic factor. During the last decade many efforts have been made to reduce rate of complications associated with lymphadenectomy (LND). A great interest has arisen in sentinel lymph node (SLN) biopsy as a technique able to decrease number of LND performed and, at the same time, to assess lymph nodal status. High diagnostic performances have been reached thanks to SLN surgical algorithm. However, despite the efforts, about 25% of these patients undergo at least unilateral LND to meet NCCN recommendations. Data of women with Internationa…

Cervical cancer; early stage; lymphadenectomy; sentinel lymph node; Oncology; Radiology Nuclear Medicine and Imaging; Cancer ResearchCancer Researchmedicine.medical_treatmentUterine Cervical NeoplasmsCervical cancer; early stage; lymphadenectomy; sentinel lymph node0302 clinical medicinesentinel lymph nodeNuclear Medicine and ImagingMedicineStage (cooking)Original ResearchCervical cancer030219 obstetrics & reproductive medicinemedicine.diagnostic_testSentinel nodeMiddle Agedearly stagePrognosisOncology030220 oncology & carcinogenesisLymphatic MetastasisFemaleRadiologyAlgorithmAlgorithmsAdultmedicine.medical_specialtySentinel lymph nodeUnnecessary ProceduresHysterectomy03 medical and health sciencesBiopsyHumansRadiology Nuclear Medicine and imagingRadical HysterectomyAgedNeoplasm StagingRetrospective StudiesHysterectomybusiness.industrySentinel Lymph Node BiopsyClinical Cancer Researchmedicine.diseaseSurgerySettore MED/40 - GINECOLOGIA E OSTETRICIAlymphadenectomyCervical cancerLymph Node ExcisionLymphadenectomyNeoplasm Gradingbusiness
researchProduct

Office hysteroscopic treatment of a vanishing external uterine orifice in a postmenopausal woman with an obstetrical history of 44 abortions

2015

Abstract Cervical stenosis, defined as cervical scarring of variable degree, represents a significant anatomical impediment to hysteroscopic procedures. Acquired cervical stenoses are more common than congenital forms and they are mainly associated with aging, estrogen–progesteron drugs, cervical trauma or carcinoma. The overcoming of cervical stenosis at office hysteroscopy is challenging and it often fails requiring the scheduling of the patient for an in-patient treatment under general anesthesia. We report the office hysteroscopy treatment of a vanishing external uterine orifice in a postmenopausal woman with an ultrasonographic report of a heterogeneous and thick endometrium suggestive…

Cervical stenosis; External uterine orifice; Hysteroscopy; Obstetrics and Gynecologymedicine.medical_specialtymedicine.diagnostic_testbusiness.industryCervical traumaObstetrics and GynecologyHysteroscopyEndometrial pathologyCervical stenosiEndometriummedicine.diseaseSettore MED/40 - Ginecologia E Ostetricialcsh:Gynecology and obstetricsExternal uterine orificeSurgerycervical stenosisStenosismedicine.anatomical_structureHysteroscopymedicineCarcinomabusinesslcsh:RG1-991
researchProduct

HIPEC for gynaecological malignancies: A last update (Review)

2023

Advanced-stage gynaecological cancer represents a clinical entity with challenging surgical treatment in an effort to optimize prognosis. Hyperthermic intraperitoneal chemotherapy (HIPEC) following cytoreductive surgery (CRS) has been reported as a method potentially eligible to improve prognosis. However, no definitive conclusions have yet been made on which types of cancer and which context HIPEC may actually have a beneficial impact. The present review discusses the efficacy and safety of HIPEC as a treatment option for patients with primary/recurrent ovarian, endometrial and cervix cancer, as well as peritoneal sarcomatosis. A literature search was conducted using MeSH terms for each top…

Cervix cancerEndometrium cancerOvarian cancerGynaecological malignanciePeritoneal sarcomatosiCytoreductive surgeryHyperthermic Intraperitoneal ChemotherapyUpdate.Settore MED/40 - Ginecologia E Ostetricia
researchProduct

Tertiary cytoreduction in the setting of recurrent ovarian cancer (Review)

2013

Ovarian cancer is the most lethal gynecological malignancy, with aggressive surgical debulking and adjuvant chemotherapy as the main treatment modalities. Optimal debulking during the primary surgery is significantly correlated with prolonged survival. As surgical techniques and chemotherapeutic agents improve, more patients with prolonged survival may face secondary and tertiary recurrences. The role of surgical debulking in secondary cytoreduction (SC) is not clearly defined and is based on retrospective series. The treatment of patients with primary or secondary recurrences generally consists of second-line chemotherapy, but may be performed on medically fit patients in certain circumsta…

Chemotherapymedicine.medical_specialtyCancer Researchbusiness.industrymedicine.medical_treatmentOptimal DebulkingCancerArticlesTertiary cytoreductionDebulkingmedicine.diseaseSettore MED/40 - Ginecologia E OstetriciaSurgeryOncologyAscitesmedicineStage (cooking)medicine.symptomRecurrent ovarian cancerOvarian cancerComplicationbusinessTumoral debulking
researchProduct

Principi di chirurgia ginecologia mininvasiva per via transaddominale.

2007

Chirurgia mininvasiva laparoscopia minilaparotomiaSettore MED/40 - Ginecologia E Ostetricia
researchProduct

Sarcoma Botryoides: Optimal Therapeutic Management and Prognosis of an Unfavorable Malignant Neoplasm of Female Children

2023

Embryonal rhabdomyosarcoma (ERMS) is a rare malignancy and occurs primarily in the first two decades of life. Botryoid rhabdomyosarcoma is an aggressive subtype of ERMS that often manifests in the genital tract of female infants and children. Due to its rarity, the optimal treatment approach has been a matter of debate. We conducted a search in the PubMed database and supplemented it with a manual search to retrieve additional papers eligible for inclusion. We retrieved 13 case reports and case series, from which we summarized that the current trend is to approach each patient with a personalized treatment plan. This consists of a combination of local debulking surgery and adjuvant or neoad…

Clinical BiochemistryEmbryonal rhabdomyosarcoma Fertility-sparing surgery Genital tract Local debulking Neoadjuvant chemotherapy Prognosis Radiation Sarcoma botryoides TreatmentSettore MED/40 - Ginecologia E OstetriciaDiagnostics
researchProduct